Search

Your search keyword '"Domènech, E."' showing total 730 results

Search Constraints

Start Over You searched for: Author "Domènech, E." Remove constraint Author: "Domènech, E."
730 results on '"Domènech, E."'

Search Results

52. Disease severity in familial cases of IBD

55. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case‐control study

58. OP034 The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry

71. P1260: UNRAVELING THE GENETICS OF TRANSFORMED SPLENIC MARGINAL ZONE LYMPHOMA

72. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

75. Prevalence and outcomes of acute-on-chronic liver failure among cirrhotic patients admitted for an acute decompensation

76. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

77. Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry

80. DOP78 Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD)

81. P289 Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: National multicenter study (ENEIDA registry). MIC project

84. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

87. A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection

90. Noninvasive assessment of liver fibrosis in Crohn's disease patients exposed to methotrexate

91. Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

92. Dietary habits in patients with fibromyalgia: A cross-sectional study

93. P022 Pathologic involvement of the farnesoid X receptor/fibroblast growth factor 19 axis to the Crohn’s disease early postsurgical recurrence

94. P671 Effect of genetic polymorphisms in the folate pathway on the efficacy and safety of methotrexate in Crohn’s disease

95. P262 Effectiveness and safety of ustekinumab in elderly patients: Real world evidence from ENEIDA registry

96. P630 Inflammatory bowel disease in immigrants to Spain: results of the EIIMIGRA study from GETECCU (ENEIDA registry)

97. DOP31 Management and outcome of postoperative Crohn’s Disease in the elderly as compared to young adults: Data from Eneida registry

98. Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU

100. DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study

Catalog

Books, media, physical & digital resources